Raised $216M across disclosed rounds.[1][2][4][9]

Series C closed January 2022, led by Lightspeed Venture Partners.[1][2][4][9]

post-money valuation is not publicly disclosed.

Named investors include Lightspeed Venture Partners, Tiger Global, Coatue, Salesforce Ventures, CRV, Tusk Venture Partners, Silverton Partners, J.P. Morgan.[1][2][5][9]

Michelle Davey, Founder & CEO[3][10][15]

Griffin Mulcahey, Co-founder[3][10][15]

Kristina Omari, Chief Financial Officer[6][15]

Michelle Monaco, Chief Product Officer[6][15]

Chris Moose, VP Life Sciences[6][15]

James Coates, VP of Commercial Strategy[6][15]

SteadyMD · steadymd.com · TechCrunch names SteadyMD as a direct alternative building an AWS-for-healthcare model that competes with Wheel for the same white-label virtual care infrastructure buyer.[1]

Teladoc · teladoc.com · TechCrunch and MedCity News both name Teladoc as a white-label telehealth option that competes for the same companies wanting to scale compliant virtual care.[1][4]

Truepill · truepill.com · TechCrunch names Truepill alongside Teladoc as a white-label solution that has powered unicorns like Hims and Hers, Nurx, and GoodRx, the same buyer Wheel targets.[1]

Doxy.me · doxy.me · CB Insights lists Doxy.me among Wheel's competitors in the virtual care platform market, competing for the same telehealth infrastructure budget.[7]

The customer proof is company-sourced only. No independent source in this ledger confirms it.[6]

Ask for one referenceable production customer.

Not a recommendation. The first thing this ledger cannot answer.

Filled in the side panel for invited readers. This card carries sourced facts only.